Abnormal prostate development in C3(1)‐bcl‐2 transgenic mice

No abstract is available for this paper.

• Publication year

  1997

• Venue

  The Prostate

• Publication date

  1997-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/(SICI)1097-0045(19970615)32:1<16::AID-PROS3>3.0.CO;2-APMID 9207953
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prostate cancer in a transgenic mouse.

  1995cited by this paper
• The role of stromal-epithelial interaction in normal and malignant growth.

  1995cited by this paper
• Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo.

  1995cited by this paper
• bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer.

  1994cited by this paper
• Bcl-2 and the regulation of programmed cell death

  1994cited by this paper
• Enhanced expression of p53 mRNA and protein in the regressing rat ventral prostate gland.

  1994cited by this paper
• Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene.

  1994cited by this paper
• Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death.

  1993cited by this paper
• Rodent models for targeted oncogenesis of the prostate gland

  1993cited by this paper
• Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers.

  1993cited by this paper
• Response elements of the androgen-regulated C3 gene.

  1992cited by this paper
• Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer.

  1992cited by this paper
• Response elements of the androgen-regulated C3 gene.

  1992cited by this paper
• A simple screening method for transgenic mice using the polymerase chain reaction.

  1990cited by this paper
• Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

  1990cited by this paper
• A simple screening method for transgenic mice using the polymerase chain reaction.

  1990cited by this paper
• Clinical and experimental studies of benign prostatic hyperplasia.

  1990cited by this paper
• Pathology of benign prostatic hyperplasia. Insight into etiology.

  1990cited by this paper
• Induction of dorsolateral prostate adenocarcinomas and other accessory sex gland lesions in male Wistar rats by a single administration of N-methyl-N-nitrosourea, 7,12-dimethylbenz(a)anthracene, and 3,2'-dimethyl-4-aminobiphenyl after sequential treatment with cyproterone acetate and testosterone pr

  1990cited by this paper
• The promotional effect of testosterone on induction of prostate-cancer in MNU-sensitized L-W rats.

  1989cited by this paper
• Involvement of the bcl-2 gene in human follicular lymphoma.

  1985cited by this paper
• Rat prostatic steroid binding protein: DNA sequence and transcript maps of the two C3 genes.

  1983cited by this paper
• Prostatic steroid-binding protein. Isolation and characterization of C3 genes.

  1983cited by this paper
• The Treatment of Ureters Injured during Gynecologic Operations

  1945cited by this paper

• Diverse Landscape of Genetically Engineered Mouse Models: Genomic and Molecular Insights into Prostate Cancer.

  2024cites this paper
• Signaling Pathways That Control Apoptosis in Prostate Cancer

  2021cites this paper
• Differential gene expression of BCL‐2, ZEB2‑AS1 and BALR‐2 in prostate cancer and benign prostatic hyperplasia

  2021cites this paper
• Anti-Proliferative Effects of Standardized Cornus officinalis on Benign Prostatic Epithelial Cells via the PCNA/E2F1-Dependent Cell Cycle Pathway

  2020cites this paper
• BCL-2 and BCL-XL expression are down-regulated in benign prostate hyperplasia nodules and not affected by finasteride and/or celecoxib.

  2018cites this paper
• Single and Multiple Gene Manipulations in Mouse Models of Human Cancer

  2015cites this paper
• Phage Display Library Screening for PSA-/lo Prostate Cancer Cell-Binding Peptides

  2014cites this paper
• Murine Models of Prostate Cancer

  2013cites this paper
• Generation of a stepwise prostate carcinogenesis model. A study of epithelial to mesenchymal transition and malignant transformation of prostate primary epithelial cells

  2013cites this paper
• Genetically engineered mouse models of prostate cancer

  2013influential citation
• Current mouse and cell models in prostate cancer research.

  2013cites this paper
• Animal modeling of cancer pathology and studying tumor response to therapy.

  2012cites this paper
• Modeling prostate cancer: a perspective on transgenic mouse models

  2010cites this paper
• Wnt/β-Catenin activation promotes prostate tumor progression in a mouse model

  2010cites this paper
• FLIP-ping out: Death receptor signaling in the prostate

  2008cites this paper
• Animal Models of Prostate Cancer

  2008cites this paper
• Survey of genetically engineered mouse models for prostate cancer: Analyzing the molecular basis of prostate cancer development, progression, and metastasis

  2005cites this paper
• Genetically modified mice and their use in developing therapeutic strategies for prostate cancer.

  2004cites this paper
• Prostatic intraepithelial neoplasia and intestinal metaplasia in prostates of probasin‐RAS transgenic mice

  2004cites this paper
• Prostate development and carcinogenesis.

  2003cites this paper
• Animal models of prostate cancer.

  2003cites this paper
• Integrated, molecular engineering approaches to develop prostate cancer gene therapy.

  2003cites this paper
• Oncogenes and Tumour Suppressor Genes in Prostate Cancer

  2003cites this paper
• Primary and Secondary Events in Oncogene-Driven Tumor Development

  2003cites this paper
• Oncogene-Directed Therapies

  2003cites this paper
• Hormone-refractory prostate cancer: a multi-step and multi-event process

  2001cites this paper
• Autochthonous mouse models for prostate cancer: past, present and future.

  2001cites this paper
• Transgenics in Endocrinology

  2001cites this paper
• Transgenic Mouse Models of Prostate Cancer

  2001cites this paper
• Functional Analysis of the Bcl2 Gene Family in Transgenic Mice

  2001cites this paper
• Protooncogenes as mediators of apoptosis.

  2000cites this paper
• Prostatic neoplasia in transgenic mice with prostate‐directed overexpression of the c‐myc oncoprotein

  2000cites this paper
• Absence of proximal duct apoptosis in the ventral prostate of transgenic mice carrying the C3(1)‐TGF‐β type II dominant negative receptor

  2000cites this paper
• Molecular genetics of prostate cancer.

  2000cites this paper
• The impact of bcl-2 expression and bax deficiency on prostate homeostasis in vivo

  2000influential citation
• The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma

  2000influential citation
• Mouse models of prostate cancer

  1999cites this paper
• Chapter 3 Animal model systems for the study of prostate cancer

  1999cites this paper
• Transgenic mice in apoptosis research

  1998cites this paper
• Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins

  1998cites this paper
• Molecular Regulation of Cell Death and Therapeutic Strategies for Cell Death Induction in Prostate Carcinoma

  1998cites this paper
• Apoptosis during castration-induced regression of the prostate is Fos dependent

  1998cites this paper
• The C3(1)/SV40 T Antigen Transgenic Mouse Model of Prostate and Mammary Cancer

  1998cites this paper
• Workgroup 3: Transgenic and reconstitution models of prostate cancer

  1998cites this paper